NASDAQ:TOTA Tottenham Acquisition I (TOTA) Stock Price, News & Analysis → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free TOTA Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$10.82▼$10.8250-Day Range$10.82▼$12.9752-Week Range$10.30▼$17.50VolumeN/AAverage Volume36,696 shsMarket Capitalization$37.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tottenham Acquisition I alerts: Email Address Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> About Tottenham Acquisition I Stock (NASDAQ:TOTA)Tottenham Acquisition I Limited does not have significant operations. The company intends to enter into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It focuses on the technology, media, telecom, education, e-commerce, health-care, and consumer goods industries with primary operations in Asia. The company was founded in 2017 and is based in Central, Hong Kong.Read More Ad Behind the MarketsTiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.Find out more here >>> TOTA Stock News HeadlinesApril 19, 2024 | msn.comMan Utd wages: Top 11 earners at Old Trafford revealed as Ratcliffe prepares to shred colossal wage billApril 9, 2024 | msn.comHull City: Sky Sports pundit makes £15m Jaden Philogene, Aston Villa predictionApril 20, 2024 | DTI (Ad)Biden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereApril 9, 2024 | msn.comBirmingham City complete purchase of new home siteApril 6, 2024 | msn.comThe Dublin bookmaker winning big with its bet on the US – for nowApril 4, 2024 | msn.comTottenham in talks with 'prospective investors', says LevyApril 3, 2024 | abcnews.go.comTottenham reports record $691M revenues and says it's 'in discussions with prospective investors'April 1, 2024 | msn.comMan Utd, Tottenham poised to strike as true price needed to sign 72-goal Prem striker is revealedApril 20, 2024 | Behind the Markets (Ad)Tiny Biotech Stock Wins $75 Billion PatentA little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.April 1, 2024 | msn.comTottenham finally ready to accept £20-25m offer for unhappy star not fully cut out for ‘Ange-Ball’March 29, 2024 | msn.comTottenham want £52m-rated versatile midfielder with 11 goal contributions this seasonMarch 28, 2024 | msn.com'Certainly appreciated at Tottenham', '…entering into concrete talks' – Romano drops latest Raphinha updateMarch 28, 2024 | msn.comClub expects Tottenham to offer €50-60m for star with 21 goal contributions this seasonMarch 26, 2024 | msn.comTrump’s social media company to start trading on the Nasdaq on TuesdayMarch 15, 2024 | msn.comCowboys EVP Stephen Jones says he understands fans frustrationMarch 15, 2024 | msn.comThe 32 worst ever Premier League playersMarch 14, 2024 | msn.comThe 29 weirdest transfer moments everMarch 13, 2024 | msn.comTottenham staff totally unconvinced by player as he decides to quit SpursMarch 11, 2024 | msn.comOscars' In Memoriam Begins With A Political Figure Far From HollywoodFebruary 23, 2024 | msn.comAston Villa 'not convinced' by permanent Nicolo Zaniolo dealFebruary 21, 2024 | sg.news.yahoo.comFrenkie de Jong: Barcelona star hits out at journalist 'lies' over transfer rumoursFebruary 21, 2024 | msn.comManchester United plans to accelerate after Ratcliffe completes dealFebruary 6, 2024 | msn.comEPL Winter Transfer Window SummaryFebruary 5, 2024 | msn.comWolves could have made Cunha even better by signing EFL sensationFebruary 5, 2024 | msn.comBreaking News: Nusa to make summer transfer as Tottenham finalize another acquisition.January 17, 2024 | msn.comSpurs make contact to sign Radu Dragusin 2.0 in "brilliant" titanJanuary 7, 2024 | msn.comWhat Timo Werner loan means for Tottenham non-homegrown numbers ahead of more January transfersSee More Headlines Receive TOTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tottenham Acquisition I and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry Holding & Other Investment Offices Sub-IndustryN/A Current SymbolNASDAQ:TOTA CUSIPN/A CIKN/A WebN/A Phone852-3998-4852FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$270,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-1.14% Return on Assets-1.05% Debt Debt-to-Equity RatioN/A Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$7.63 per share Price / Book1.42Miscellaneous Outstanding Shares3,456,000Free FloatN/AMarket Cap$37.39 million OptionableNot Optionable Beta0.05 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesMr. Jason Ma (Age 47)Chairman & CEO Mr. Felix WongCFO & Director This page (NASDAQ:TOTA) was last updated on 4/20/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsSHOCKING Crypto Leak…Crypto 101 MediaThe #1 Crypto for 2024InvestorPlaceBiden’s $374B Giveaway Into This SectorDTIDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tottenham Acquisition I Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.